ARTICLE | Company News
EC approves Merck's Sycrest
September 3, 2010 12:06 AM UTC
The European Commission approved an MAA from Merck & Co. Inc. (NYSE:MRK) for Sycrest asenapine to treat moderate to severe manic episodes associated with bipolar I disorder. Merck markets the serotoni...